Company: TISI
Filing Date: 2025-10-09
Form Type: S-3
Source: 0001193125-25-235868
Chunk: 13

Company: TEAM INC
Filing Date: 2025-10-09
Form: S-3
Chunk 13
---
 as well as those risk factors described in any applicable prospectus supplement and in the documents we incorporate by reference in this prospectus, for a 
 discussion of factors to consider carefully before deciding to invest in shares of our common stock.                                                                                                                                  |

| Stock exchange listing: | Our common stock is listed on the New York Stock Exchange under the symbol “TISI.” |

4

RISK FACTORS

An investment in our securities involves a high degree of risk. Before you decide whether to purchase any of our securities, in addition to
the other information, documents or reports included in or incorporated by reference into this prospectus and any accompanying prospectus supplement or other offering materials, you should carefully consider the risk factors in the section entitled
“Risk Factors” in any prospectus supplement as well as in the 2024 Annual Report and any subsequent Quarterly Reports on Form 10-Q or Current Reports on
Form 8-K, which are incorporated by reference into this prospectus and any prospectus supplement, as the same may be amended, supplemented or superseded from time to time by our filings under the Exchange
Act. If any of these risks were to materialize, either individually or in combination, our business, financial condition or results of operations could be adversely affected. In that case, the trading price of our common stock or debt securities
could decline and you could lose all or part of your investment. When we offer and sell any securities pursuant to a prospectus supplement, we may include additional risk factors relevant to such securities in the prospectus supplement.

5

USE OF PROCEEDS

We are filing the Registration Statement of which this prospectus is a part to permit the holders of the shares of common stock issuable upon
an exercise in full of the Warrants, as described in the section entitled “Selling Securityholders” of this prospectus, to resell such shares of our common stock from time to time. We are not selling any securities under this prospectus
and will not receive any proceeds from the sale of shares by a selling securityholder. We will receive proceeds from any cash paid upon a cash exercise of the Warrants, which will be used for working capital and general corporate purposes. The
Warrants may also be exercised on a cashless basis subject to the terms set forth in the Warrants based on the net difference between the exercise price and the market price of our common stock on the last trading day preceding the date of exercise
of the Warrants. If the Warrants are exercised on a